SEC Form 4 · accession 0001179110-18-005603
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Elizabeth Stoner
Director
Period of report
Mar 21, 2018
Accepted (ET)
Apr 12, 2018 · 4:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 21, 2018 | M | 5,000 | $8.85 | A | 21,176 | D | |
| Common Stock | Mar 21, 2018 | S | 3,399 | $19.00 | D | 17,777 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $8.85 | Mar 21, 2018 | M | 5,000 | D | Jun 11, 2010 | Jun 11, 2019 | Common Stock | 5,000 | 5,000 | D |
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 trading plan.